Two Sigma Investments, LP Organon & Co. Transaction History

Two Sigma Investments, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $2.41 Million - $3.62 Million	-112,739 Reduced 92.23%	9,500 $223,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $2.85 Million - $3.5 Million	122,239 New	122,239 $3.42 Million
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $894,468 - $1.16 Million	-29,375 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$28.67 - $37.13 $22,936 - $29,704	800 Added 2.8%	29,375 $894,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $357,903 - $445,535	-12,501 Reduced 30.43%	28,575 $937,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $1.17 Million - $1.56 Million	41,076 New	41,076 $1.24 Million

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.